Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema

International Ophthalmology

Volumn 37, Issue 1, 2017, Pages 1-6

  Esen, Ebru ^a   Sizmaz, Selcuk ^a   Demircan, Nihal ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Best corrected visual acuity; Central macular thickness; Dexamethasone implant; Persistent diabetic macular edema

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; HEMOGLOBIN A1C; LOMEFLOXACIN; RANIBIZUMAB; TRIAMCINOLONE ACETATE; TRIAMCINOLONE ACETONIDE; DELAYED RELEASE FORMULATION; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BEST CORRECTED VISUAL ACUITY; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; INTRAVITREAL IMPLANT; LASER COAGULATION; MACULAR EDEMA; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; RETREATMENT; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; ADMINISTRATION AND DOSAGE; DELAYED RELEASE FORMULATION; DIABETIC RETINOPATHY; DRUG IMPLANT; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; VISUAL ACUITY;

ADULT; AGED; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DIABETIC RETINOPATHY; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84960459925     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-016-0219-2     Document Type: Article

References (29)

1. Bhagat N, Grigorian RA, Tutela A, Zarbin MA (2009) Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 54:1–32
2. Funatsu H, Noma H, Mimura T, Eguchi S, Hori S (2009) Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116:73–79
3. ®) in patients with persistent diabetic macular edema. Clin Ophthalmol 7:1423–1428
4. Ho AC, Scott IU, Kim SJ, Brown GC, Brown MM, Ip MS, Recchia FM (2012) Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology 119:2179–2188
5. Grover D, Li TJ, Chong CC (2008) Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev 1:CD005656
6. Bandello F, Preziosa C, Querques G, Lattanzio R (2014) Update of intravitreal steroids for the treatment of diabetic macular edema. Ophthalmic Res 52:89–96
7. Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B (2006) Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema. Eur J Ophthalmol 16:566–672
8. Gillies MC, Sutter FK, Simpson JM et al (2006) Intravitreal triamcinolone for refractory diabetic macular edema two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113:1533–1538
9. Herrero-Vanrell Cardillo JA, Kuppermann BD (2011) Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol 5:139–146
10. Boyer DS, Yoon YH, Belfort R Jr et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121:1904–1914
11. Virgili G, Parravano M, Menchini F, Evans JR (2014) Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev 10:CD007419
12. Totan Y, Güler E, Gürağaç FB (2015) Dexamethasone intravitreal implant for chronic diabetic macular edema resistant to intravitreal bevacizumab treatment. Curr Eye Res 22:1–7
13. Lazic R, Lukic M, Boras I et al (2014) Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant. Retina 34:719–724
14. Dutra Medeiros M, Postorino M, Navarro R, Garcia-Arumí J, Mateo C, Corcóstegui B (2014) Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema. Ophthalmologica 231:141–146
15. ®)) in treatment of recalcitrant diabetic macular edema: a case series. Oman J Ophthalmol 5:79–82
16. Zucchiatti I, Lattanzio R, Querques G et al (2012) Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica 228:117–122
17. Zalewski D, Raczyńska D, Raczyńska K (2014) Five-month observation of persistent diabetic macular edema after intravitreal injection of Ozurdex implant. Mediators Inflamm 2014:364143
18. Scaramuzzi M, Querques G, Spina C, Lattanzio R, Bandello F (2015) Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema. Retina 35:1216–1222
19. Escobar-Barranco JJ, Pina-Marín B, Fernández-Bonet M (2015) Dexamethasone implants in patients with naïve or refractory diffuse diabetic macular edema. Ophthalmologica 233:176–185
20. Tamura H, Miyamoto K, Kiryu J et al (2005) Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 46:1440–1444
21. Nauck M, Roth M, Tamm M et al (1997) Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 16:398–406
22. Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR et al (2007) Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114:525–536
23. Haller JA, Bandello F, Belfort R Jr et al (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134–1146
24. Bonnin S, Dupas B, Sanharawi ME et al (2015) Efficacy of dexamethasone intravitreal implant for the treatment of diabetic macular edema. Eur J Ophthalmol. doi:10.5301/ejo.5000581
25. Panozzo G, Gusson E, Panozzo G, Mura GD (2015) Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment. Eur J Ophthalmol 25:347–351
26. Arıkan Yorgun M, Toklu Y (2015) Comment on the article by Dutra Medeiros et al. entitled ‘dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema’. Ophthalmologica 233:117–118
27. Pacella E, La Torre G, Impallara D et al (2013) Efficacy and safety of the intravitreal treatment of diabetic macular edema with pegaptanib: a 12-month follow-up. Clin Ter 164:e121–e126
28. Kook D, Wolf A, Kreutzer T et al (2008) Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina 28:1053–1060
29. Pacella E, La Torre G, Turchetti P et al (2014) Evaluation of efficacy dexamethasone intravitreal implant compared to treatment with anti-VEGF in the treatment of diabetic macular edema. Senses Sci 1:164–168